AGL 37.89 Decreased By ▼ -0.26 (-0.68%)
AIRLINK 124.10 Increased By ▲ 2.59 (2.13%)
BOP 5.67 Decreased By ▼ -0.18 (-3.08%)
CNERGY 3.75 No Change ▼ 0.00 (0%)
DCL 8.55 Increased By ▲ 0.15 (1.79%)
DFML 40.48 Decreased By ▼ -0.41 (-1%)
DGKC 87.10 Increased By ▲ 2.50 (2.96%)
FCCL 33.98 Increased By ▲ 1.28 (3.91%)
FFBL 66.01 Increased By ▲ 0.51 (0.78%)
FFL 10.20 Increased By ▲ 0.15 (1.49%)
HUBC 104.45 Increased By ▲ 0.65 (0.63%)
HUMNL 13.45 Increased By ▲ 0.20 (1.51%)
KEL 4.78 Increased By ▲ 0.35 (7.9%)
KOSM 6.84 Decreased By ▼ -0.25 (-3.53%)
MLCF 38.84 Increased By ▲ 1.34 (3.57%)
NBP 60.35 Increased By ▲ 0.10 (0.17%)
OGDC 179.65 Increased By ▲ 7.40 (4.3%)
PAEL 24.97 Increased By ▲ 0.17 (0.69%)
PIBTL 5.71 Increased By ▲ 0.01 (0.18%)
PPL 153.00 Increased By ▲ 11.31 (7.98%)
PRL 22.79 Increased By ▲ 0.07 (0.31%)
PTC 14.91 Increased By ▲ 0.17 (1.15%)
SEARL 66.85 Increased By ▲ 2.29 (3.55%)
TELE 7.01 Decreased By ▼ -0.13 (-1.82%)
TOMCL 35.70 Increased By ▲ 0.20 (0.56%)
TPLP 7.32 Increased By ▲ 0.03 (0.41%)
TREET 13.99 Decreased By ▼ -0.21 (-1.48%)
TRG 50.95 Decreased By ▼ -0.80 (-1.55%)
UNITY 26.40 Decreased By ▼ -0.20 (-0.75%)
WTL 1.23 Increased By ▲ 0.01 (0.82%)
BR100 9,717 Increased By 233.5 (2.46%)
BR30 29,237 Increased By 866.2 (3.05%)
KSE100 90,860 Increased By 1893.1 (2.13%)
KSE30 28,458 Increased By 630.4 (2.27%)

Britain's top share index slipped on Monday as news of China's slowing economy sapped mining stocks and drugmaker Shire dipped after US regulators withheld approval for a new drug. Britain's FTSE 100 index closed down 25.71 points, 0.4 percent, at 6,352.33 points at the close, underperforming European indexes. Mining shares fell along with metals prices after China reported that economic growth slowed in the third quarter. While the data were slightly stronger than expected, growth was still at its weakest since 2009, reflecting a sluggish global economy that is hurting demand for metals.
Anglo American fell 7.4 percent. Glencore, Antofagasta and BHP Billiton were all down 3 to 5.2 percent. Chinese manufacturing data came in weaker than forecast. "Given the relatively poor performance of manufacturing, that is probably a reason why ... mining stocks have taken a little bit of a dent," said Laith Khalaf, senior analyst at Hargreaves Lansdown.
Despite a rally of around 5 percent so far in October, the FTSE 100 remains down about 10 percent from record highs reached in April. Pharmaceutical company Shire turned positive in afternoon trade. The stock had fallen after the US Food and Drug Administration declined to approve its dry-eye drug, lifitegrast, and requested an additional clinical study. Shire's chief executive said the company still plans a potential 2016 launch for the drug.
"We believe the CRL (Complete Response Letter) was fairly well anticipated by the market, with Shire having been warning of the risk of a delay, pending more clinical data, for the last few months," analysts at J.P. Morgan wrote in a note. Barclays rose 1.5 percent after Financial Times report that it will speed up the reduction in size of its investment bank.

Copyright Reuters, 2015

Comments

Comments are closed.